ACIP Presentation Slides: February 23-24, 2022 Meeting

Note: These files are not yet 508

Slides will be added as they become available.

February 23, 2022

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Tickborne Encephalitis (TBE) Vaccine

• Introduction [5 pages]
  Dr. K Poehling
• Review of considerations for use of TBE vaccine in travelers and laboratorians [36 pages]
  Dr. S Hills

Cholera Vaccine

• Introduction [4 pages]
  Dr. P Sanchez
• Clinical considerations for use of cholera vaccine in children and adolescents aged 2–17 years [34 pages]
  Dr. J Collins

Influenza Vaccine

• Introduction [4 pages]
  Dr. K Talbott
• Influenza activity update [7 pages]
  Dr. L Grohskopf
• Recommending enhanced seasonal influenza vaccines in adults age 65 and older–potential impacts on influenza burden [13 pages]
  Dr. S Morris
• Influenza vaccines for older adults [52 pages]
  Dr. L Grohskopf

Hepatitis Vaccine

• Introduction [4 pages]
  Dr. K Ault
• PREHEVBRIO for adult HepB vaccination: EtR and GRADE [30 pages]
  Dr. M Weng

MMR Vaccine Workgroup

• Introduction [9 pages]
  Ms. L Bhata
• MMR safety and immunogenicity [25 pages]
  Dr. R Abu-Elyazeed

February 24, 2022

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Agency Updates

• CMS, FDA, HRSA, HIS, OIDP, NIH

Pneumococcal Vaccines

• Introduction [12 pages]
  Dr. K Poehling
  
• Epidemiology of pneumococcal disease and pneumococcal vaccine coverage in US children [28 pages]
  Mr. R Gierke
• PCV15 Phase 2/3 study results in children [32 pages]
  Dr. N Banniettis
• GRADE and EtR for PCV15 use in U.S. children [62 pages]
  Ms. J Farrar
• Summary and next steps [7 pages]
  Dr. M Kobayashi

Vaccine Supply

• Dr. J Santoli